Creating the Seegene OneSystem™ Global Consortium

At Seegene, we aspire to create a world free from all diseases and future pandemics so that the world may not repeat history such as the COVID-19 pandmic. Now more than ever, this is a necessary endeavor and more importantly, we believe we have the necessary factors to make this vision a reality.

We believe early testing and diagnosis are key pillars towards this vision. Early testing and diagnosis pave the way for early treatment which can lead to healthier lives and, thus, a world free from all diseases.
The best tool available today for early and accurate diagnosis for various diseases is PCR testing and, in this field, Seegene stands out.

Seegene has always been a game changer. Our high multiplex syndromic technologies make it possible for Seegene to be the only company in the world whose panels allow targeting of up to 14 pathogens. Seegene Digitalized Development System (SGDDS), our automated development system, allows more robust accelerated product development processes that others cannot match. And our modular instrument approach allows for agile configuration.  

With Seegene's industry-unique solutions being battle tested during the COVID-19 pandemic and successfully proving its effectiveness, Seegene is now prepared to share its technologies and know-how with the world by creating a global consortium with a common purpose to make PCR testing a part of our daily routine and enable a world free from all diseases and future pandemics. This global consortium will be based on our technologies called Seegene OneSystem™.

But we cannot do this alone.

Seegene PCR Technologies and Microsoft AI – Opening a New Chapter in Assay Development

This past January, Seegene and Microsoft announced a strategic collaboration between the two companies. With this announcement made in London, Seegene will work with Microsoft to create technology partnerships that will help advance the Seegene OneSystem™ operations.

- Standardizing IT infrastructure: As we expand our global consortium partner network for our
  OneSystem™ business, we will make Microsoft Azure the standard for our IT and cloud infrastructure to
  maximize operational efficiency.

- Adopting Microsoft’s AI technology: The breakthrough collaboration will be incorporate AI technologies
  from Azure, including Azure OpenAI Service, into the Seegene Digitalized Development System(SGDDS),
  which automates oligo design, experimental design, and more, to maximize product research and
  development efficiency. This will drastically reduce the barriers to product development and advance
  the global consortium’s product development capabilities. We believe this opens up a new chapter in
  how products are developed in the future.

- Improving data analysis and uses: We will utilize Microsoft Fabric and Microsoft Copilot to effectively
  analyze the vast amount of research data we have accumulated over the years to improve research
  efficiency and productivity.

Microsoft, an Advocate of a World Free From All Diseases and OneSystem™ Business

At the same time, this relationship goes beyond breakthrough technological partnership; it facilitates collaboration between the two companies to accelerate the formation of the Seegene OneSystem™ global consortium as well as innovate how the healthcare industry works.

- Joint Declaration: The companies will globally announce their commitment through a joint declaration
  aiming for a world free from diseases.

- Global Consortium Partnership: Under Seegene's OneSystem™ business, a global consortium of
  medical partners will be created to standardize and popularize advanced molecular diagnostics
  worldwide. Microsoft will support this consortium by serving as the bridge between its Azure clients and
  Seegene to facilicate potential partnerships.

- Advancing joint research: Seegene and Microsoft will collaborate on research into next-generation PCR
  data management and analytics that can contribute to disease prevention and treatment, and healthcare
  innovations based on them.

- Advancing healthcare: Our collaboration will serve as an example of successful business cooperation in
  healthcare, and we will continue to collaborate and innovate in new areas of healthcare, aiming for
  breakthroughs.

Days of Resilience Lead to a Purposeful Vision

This collaboration holds personal significance for Dr. Jong-Yoon Chun, CEO of Seegene, whose childhood battle with tuberculosis motivated him to dream of a future no one else has to suffer in the same way. Microsoft’s confidence in his vision played a crucial role in making this strategic collaboration a reality.

Looking Ahead: The Promise of a New Era in Healthcare

The journey that Seegene and Microsoft have embarked on together holds vast potential and inspiration. While the road ahead may be long and challenging, the synergy between these two powerhouses is set to fundamentally transform the landscape of global healthcare. Join us in supporting this visionary partnership as we move towards a healthier, disease-free world.